AN2 Therapeutics Inc (ANTX)
2.55
+0.02
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
2.55
0.00 (0.00%)
After-Hours: 19:29
AN2 Therapeutics Price to Book Value: 0.6100 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 0.6052 |
| May 01, 2024 | 0.5741 |
| April 30, 2024 | 0.5741 |
| April 29, 2024 | 0.5669 |
| April 26, 2024 | 0.555 |
| April 25, 2024 | 0.5454 |
| April 24, 2024 | 0.5741 |
| April 23, 2024 | 0.5669 |
| April 22, 2024 | 0.5634 |
| April 19, 2024 | 0.5897 |
| April 18, 2024 | 0.5682 |
| April 17, 2024 | 0.5921 |
| April 16, 2024 | 0.5897 |
| April 15, 2024 | 0.5968 |
| April 12, 2024 | 0.6541 |
| April 11, 2024 | 0.7162 |
| April 10, 2024 | 0.7258 |
| April 09, 2024 | 0.7281 |
| April 08, 2024 | 0.7186 |
| April 05, 2024 | 0.7186 |
| April 04, 2024 | 0.7759 |
| April 03, 2024 | 0.8045 |
| April 02, 2024 | 0.8117 |
| April 01, 2024 | 0.8976 |
| March 28, 2024 | 0.7759 |
| Date | Value |
|---|---|
| March 27, 2024 | 0.7687 |
| March 26, 2024 | 0.7449 |
| March 25, 2024 | 0.7663 |
| March 22, 2024 | 0.795 |
| March 21, 2024 | 0.7902 |
| March 20, 2024 | 0.7663 |
| March 19, 2024 | 0.7329 |
| March 18, 2024 | 0.7043 |
| March 15, 2024 | 0.7162 |
| March 14, 2024 | 0.725 |
| March 13, 2024 | 0.7107 |
| March 12, 2024 | 0.6917 |
| March 11, 2024 | 0.7036 |
| March 08, 2024 | 0.6988 |
| March 07, 2024 | 0.7012 |
| March 06, 2024 | 0.6845 |
| March 05, 2024 | 0.6726 |
| March 04, 2024 | 0.663 |
| March 01, 2024 | 0.7155 |
| February 29, 2024 | 0.7107 |
| February 28, 2024 | 0.7203 |
| February 27, 2024 | 0.7107 |
| February 26, 2024 | 0.7465 |
| February 23, 2024 | 0.737 |
| February 22, 2024 | 0.7894 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5454
Minimum
Apr 25 2024
5.443
Maximum
Sep 29 2023
2.436
Average
2.108
Median
Price to Book Value Benchmarks
| Gilead Sciences Inc | 4.628 |
| QuidelOrtho Corp | 0.5673 |
| CymaBay Therapeutics Inc (DELISTED) | 12.76 |
| Insmed Inc | -- |
| Revance Therapeutics Inc | -- |
Price to Book Value Related Metrics
| Price | 2.55 |
| Earnings Yield | -110.6% |
| Market Cap | 76.06M |